--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About BIOA20260220C17.5
Pharmaceutical
BioAge Labs, Inc., was incorporated in Delaware on April 1, 2015. They are a clinical-stage biopharmaceutical company developing product candidates for the treatment of metabolic diseases such as obesity by targeting the biology of human aging. Their technology platform and differentiated human datasets allow them to identify promising targets based on insights into the molecular changes that drive aging. Their main focus is metabolic disease, one of the biggest healthcare challenges in the world.
